Casey McPherson: AlphaRose Therapeutics on doing things differently
7 June 2025
Interview by Nicola Miller, RARE Revolution insider, featuring Casey McPherson, CEO, AlphaRose Therapeutics.
“The urgency we feel as parents is different”
– creating a treatment for my daughter, Rose

“We’re a public benefit corporation, which means that we’re fiducially responsible to shareholders, but we’re also fiducially responsible to our customers, which are patients. It blows my mind that healthcare companies aren’t required to have that responsibility.”